Post-Traumatic Stress Disorder (PTSD) Clinical Trials

Find Post-Traumatic Stress Disorder (PTSD) Clinical Trials Near You

A Feasibility Study of Group-Based Metacognitive Therapy (MCT) for Post-Traumatic Stress Disorder (PTSD) in a Routine Healthcare Setting

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The primary objective of this study is to investigate the feasibility and acceptability of group-based Metacognitive Therapy (MCT) for post-traumatic stress disorder (PTSD) when delivered within routine psychiatric care in Sweden. The secondary objective is to evaluate preliminary treatment effects of group-based MCT on symptoms of post-traumatic stress, complex PTSD, depression, and quality of life, and to compare treatment dropout rates to those reported in the existing literature on exposure-based treatments for PTSD.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Fulfills the diagnostic criteria for PTSD based on clinical records

• Self-rated total sum score over 30 on the PCL-5

• Age ≥18 years.

• Stable psychotropic medication regimen for ≥4 weeks.

• Fluent in Swedish.

Locations
Other Locations
Sweden
Affektiva, ångest och traumaprogrammet, Psykiatri Sydväst
RECRUITING
Stockholm
Contact Information
Primary
Maria Bragesjö
maria.bragesjo@ki.se
+46703399387
Time Frame
Start Date: 2025-11-28
Estimated Completion Date: 2026-11-28
Participants
Target number of participants: 30
Treatments
Experimental: Group-based metacognitive therapy
14 weeks of group-based meta-cognitive therapy
Related Therapeutic Areas
Sponsors
Leads: Karolinska Institutet
Collaborators: Region Stockholm

This content was sourced from clinicaltrials.gov